Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas.

× No keyword cloud information.

19 in total

1. Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo.

Authors: Young Jee Kim; Jee-Bum Lee; Seong-Jin Kim; Seung-Chul Lee; Young Ho Won; Sook Jung Yun
Journal: Ann Dermatol Date: 2015-03-24 Impact factor: 1.444

2. RAF inhibition overcomes resistance to TRAIL-induced apoptosis in melanoma cells.

Authors: Anja Berger; Sandra-Annika Quast; Michael Plötz; Nicholas-Frederik Kuhn; Uwe Trefzer; Jürgen Eberle
Journal: J Invest Dermatol Date: 2013-08-16 Impact factor: 8.551

Review 3. Melanoma: What do all the mutations mean?

Authors: Elizabeth J Davis; Douglas B Johnson; Jeffrey A Sosman; Sunandana Chandra
Journal: Cancer Date: 2018-04-17 Impact factor: 6.860

4. Local recurrence and metastasis in patients with malignant melanomas after surgery: A single-center analysis of 202 patients in South Korea.

Authors: Soo Ick Cho; Jaewon Lee; Gwanghyun Jo; Sang Wha Kim; Kyung Won Minn; Ki Yong Hong; Seong Jin Jo; Kwang Hyun Cho; Byung Jun Kim; Je-Ho Mun
Journal: PLoS One Date: 2019-03-07 Impact factor: 3.240

5. Microbiopsy engineered for minimally invasive and suture-free sub-millimetre skin sampling.

Authors: Lynlee L Lin; Tarl W Prow; Anthony P Raphael; Robert L Harrold Iii; Clare A Primiero; Alexander B Ansaldo; H Peter Soyer
Journal: F1000Res Date: 2013-05-02

6. Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.

Authors: Jin-Woo Hong; Suee Lee; Dae-Cheol Kim; Ki-Ho Kim; Ki-Hoon Song
Journal: Ann Dermatol Date: 2014-04-30 Impact factor: 1.444

7. BRAF V600 mutations and pathological features in Japanese melanoma patients.

Authors: Naoya Yamazaki; Ryota Tanaka; Arata Tsutsumida; Kenjiro Namikawa; Hironobu Eguchi; Wataru Omata; Kohei Oashi; Toru Ogawa; Amiko Hayashi; Noriyuki Nakamura; Koji Tsuta
Journal: Melanoma Res Date: 2015-02 Impact factor: 3.599

8. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.

Authors: Yi-Shuan Sheen; Yi-Hua Liao; Ming-Hsien Lin; Hsien-Ching Chiu; Shiou-Hwa Jee; Jau-Yu Liau; Yih-Leong Chang; Chia-Yu Chu
Journal: PLoS One Date: 2016-01-21 Impact factor: 3.240

Review 9. Cutaneous Melanoma in Asians.

Authors: Sang Yub Kim; Sook Jung Yun
Journal: Chonnam Med J Date: 2016-09-23

10. Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanoma.

Authors: Naoya Yamazaki; Arata Tsutsumida; Akira Takahashi; Kenjiro Namikawa; Shusuke Yoshikawa; Yutaka Fujiwara; Shunsuke Kondo; Akihira Mukaiyama; Fanghong Zhang; Yoshio Kiyohara
Journal: J Dermatol Date: 2018-02-05 Impact factor: 4.005